Bioluminescence Ventures logo

Bioluminescence Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

2

Common Fundraising Type

Series B

GEMMABio logo
GEMMABio

Gene therapy • Rare diseases

GEMMA Biotherapeutics is a therapeutics company focused on advancing gene therapy research and expanding access to therapies for rare diseases.

Seed
$34M
12/23/2024
Article
ReCode Therapeutics logo
ReCode Therapeutics

Genetic Medicines • MRNA Therapeutics

Bioluminescence Ventures logo
Solasta Ventures logo
Sanofi Ventures logo
Pfizer Ventures logo

ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.

Series B
$50M
09/19/2023
Article